Table 1.
Gene | Tumor types with somatic alterations (mutation, deletion or promoter hypermethylation) | Tumor types or syndromes with germline mutation |
---|---|---|
BRCA 1 | TNBC, HGSOC, lung cancer, prostate cancer, mCRPC, and PDAC. | TNBC, HGSOC and PDAC |
BRCA 2 | BC, HGSOC, PDAC, prostate cancer, mCRPC, gastric, bladder and lung cancer, DLBCL and sarcoma | BC, HGSOC, PDAC and leukemia |
ATM | T‑PLL, BC, GBM, ccRCC, lung adenocarcinoma, sarcoma, and prostate, gastric, bladder, colorectal, uterine and pancreatic cancer | Leukemia, lymphoma, medulloblastoma, glioma and ataxia telangiectasia |
ATR | Breast, colorectal, head and neck, gastric and uterine cancer | Oropharyngeal cancer and familial cutaneous telangiectasia and cancer syndrome |
CHEK 2 (CHK2) | Uterine cancer and HGSOC | BC |
PALB2 | Gastric cancer and HGSOC | Wilms tumor, medulloblastoma, AML, Fanconi anemia, BC, PDAC and HGSOC |
AML, acute myeloid leukemia; ATM, ataxia telangiectasia mutated; ATR, ataxia telangiectasia; DLBCL, diffuse large B cell lymphoma; GBM, glioblastoma; ccRCC, clear cell renal cell carcinoma; HGSOC, high grade serous-ovarian cancer, mCRPC, metastatic castration-resistant prostate cancer; PDAC, pancreatic ductal adenocarcinoma, TNBC, triple negative breast cancer; T‑PLL, T-cell prolymphocytic leukemia; WRN, Werner syndrome, RecQ helicase-like.